From bench to biotech
Life sciences class brings biotech industry experience into the classroom with part-time internships for graduate students.
Artificial intelligence system rapidly predicts how two proteins will attach
The machine-learning model could help scientists speed the development of new medicines.
Taking some of the guesswork out of drug discovery
A deep learning model rapidly predicts the 3D shapes of drug-like molecules, which could accelerate the process of discovering new medicines.
New 10-minute test detects Covid-19 immunity
Paper-based blood test developed by SMART researchers can rapidly determine the presence of SARS-CoV-2 neutralizing antibodies.
MIT Sloan and Bayer team up to cultivate digital intrapreneurship capability
Corporate innovation leaders at Bayer engage MIT Sloan Executive Education in a transformational data science and intrapreneurship program.
Landmark Bio, a biomanufacturing facility co-founded by MIT, breaks ground in Watertown Arsenal
Public-private partnership aims to advance development and production of medical treatments.
Enhancing drug delivery with ultrasound
Suono Bio, founded by two MIT professors and an alumnus, is using a proven technology to boost the treatment of gastrointestinal tract disorders.
Speeding up clinical trials by making drug production local
Professor Tim Jamison’s company Snapdragon Chemistry helps turn the latest innovations in chemistry into impactful drugs.
New drug-formulation method may lead to smaller pills
Chemical engineers have found a way to load more drug into a tablet, which could then be made smaller and easier to swallow.
Building robots to expand access to cell therapies
Alumni-founded Multiply Labs uses an automated manufacturing platform to produce advanced treatments at scale.
Big data dreams for tiny technologies
MIT research combines machine learning with nanoparticle design for personalized drug delivery.
Supporting the Covid-19 vaccine rollout with extra-strength glass
Corning executive Mark Kurz SM ’95 leads a team producing vials for vaccine distribution.
A new tool to investigate bacteria behind hospital infections
Scalable CRISPRi system from SMART allows scientists to identify and tackle causes of E. faecalis-related diseases and drug resistance.
SMART researchers use lysins to selectively target bacteria
The discovery can help to cure bacterial infections without inducing resistance or causing harm to good bacteria.
Regina Barzilay wins $1M Association for the Advancement of Artificial Intelligence Squirrel AI award
MIT professor announced as award’s first recipient for work in cancer diagnosis and drug synthesis.